САХАРНЫЙ ДИАБЕТ 2-ГО ТИПА У ДЕТЕЙ И ПОДРОСТКОВ: МЕЖДУНАРОДНЫЕ РЕКОМЕНДАЦИИ
Аннотация
Ключевые слова: дети, сахарный диабет 2-го типа, диагностика, лечение.
(Вопросы современной педиатрии. 2009; 8(2):49-53)
Об авторах
О.В. ВасюковаРоссия
В.А. Петеркова
Россия
Список литературы
1. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care. 2000; 23 (3): 381–389.
2. Rosenbloom A.L., Joe J.R., Young R.S. et al. The emerging epidemic of type 2 diabetes mellitus in youth. Diabetes Care. 1999; 22: 345–354.
3. Dunkan G.E. Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002. Arch. Pediatr. Adolesc. Med. 2006; 160: 523–528.
4. Pinhas-Hamiel O., Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J. Pediatr. 2005; 146: 693–700.
5. Drake A.J., Smith A., Betts P.R. et al. Type 2 diabetes in obese white children. Arch. Dis. Child. 2002; 86: 207–208.
6. Kitagawa T., Owada M., Urakami T. et al. Increased incidence of non-insulin dependent diabetes mellitus among Japanese schoolchildren correlates with an increased intake of animal protein and fat. Clin. Pediatr. 1998; 37: 111–115.
7. Ehtisham S., Hattersley A.T., Dunger D.B. et al. First UK survey of paediatric type 2 diabetes and MODY. Arch. Dis. Child. 2004; 89: 526–529.
8. Hannon T.S., Rao G., Arslanian S.A. Childhood Obesity and Type 2 Diabetes Mellitus. Pediatrics. 2005; 116: 473–480.
9. Pinhas-Hamiel O., Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007; 369: 1823–1831.
10. Rosenbloom A.L., Silverstein J.H., Amemiya S. et al. Type 2 diabetes in the child and adolescent. Pediatric Diabetes. 2008; 9: 512–526.
11. The writing group for the search for diabetes in youth study group. Incidence of diabetes in youth in the United States. JAMA. 2007; 297: 2716–2724.
12. Chan J.C., Cheung C.K., Swaminathan R. et al. Obesity, albuminuria and hypertension among Hong Kong Chinese with non–insulin dependent diabetes mellitus (NIDDM). Postgrad Med. J. 1993; 69: 204–210.
13. Wei J.N., Sung F.C., Li C.Y. et al. Low birth weight and high birth weight infants are both at an increased risk to have type 2 diabetes among schoolchildren in Taiwan. Diabetes Care. 2003; 26: 343–348.
14. Gottlieb M.S. Diabetes in offspring and siblings of juvenile and maturity onset type diabetics. J. Chronic Dis. 1980; 33: 331–339.
15. Dahlquist G., Blom L., Tuvemo T. et al. The Swedish childhood diabetes study – results from a nine year case register and a one year case referent study indicating that type 1 (insulindependent) diabetes mellitus is associated with both type 2 (non–insulin dependent) diabetes mellitus and autoimmune disorders. Diabetologia. 1989; 32: 2–6.
16. Sugihara S., Sasaki N., Kohno H. et al. Survey of current medical treatments for childhood-onset type 2 diabetes mellitus in Japan. Clin. Pediatr. Endocrinol. 2005; 14: 65–75.
17. Turner R., Stratton I., Horton V. et al. for the UK Prospective Diabetes Study (UKPDS) Group. UKPDS 25: autoantibodies to islet cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet. 1997; 350: 1288–1293.
18. Hathout E.H., Thomas W., El–Shahawy et al. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. In: Pediatrics. 2001. Р. 107–102.
19. Umpaichitra V., Banerji M.A., Castells S. Autoantibodies in children with type 2 diabetes mellitus. J. Pediatr. Endocrinol Metab. 2002; 15: 525–530.
20. Druet C., Tubiana-Rufi N., Chevenne D. et al. Characterization of insulin secretion and resistance in type 2 diabetes of adolescents. J. Clin. Endocrinol Metab. 2006; 91: 401–404.
21. UKPDS GROUP. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837–853.
22. Rosenbloom A.L. Obesity, insulin resistance, beta cell autoimmunity, and the changing clinical epidemiology of childhood diabetes. Diabetes Care. 2003; 26: 2954–2956.
23. Reinhard T., Schober E., Wiegand S. et al. Оn behalf of the DPV–Weiss Study Group. B-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch. Dis. Child. 2006; 91: 473–477.
24. Landin-Olsson M. Latent autoimmune diabetes in adults. Ann. N.Y. Acad. Sci. 2002; 958: 112–116.
25. Craig M., Hattersley A., Donaghue K. Definition, epidemiology, diagnosis and classification. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Pediatr. Diabetes. 2006; 7: 343–351.
26. World Health Organisation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO/NCD/NCS/99.2 1999.
27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes. Care. 2008; 31: 55–60.
28. Miller J., Silvestein J.H., Rosenbloom A.L. Type 2 diabetes in the child and adolescent. Pediatric Endocrinology. 2007; 1: 169–188.
29. Wiegand S., Maikowski U., Blankenstein O. et al. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity – a problem that is no longer restricted to minority groups. Eur. J. Endocrinol. 2004; 151: 199–206.
30. Goran M.I., Bergman R.N., Avila Q. et al. Impaired glucose tolerance and reduced b-cell function in overweight Latino children with a positive family history for type 2 diabetes. J. Clin. Endocrinol. Metab. 2004; 89: 207–212.
31. Freedman D.S., Khan L.K., Dietz W.H. et al. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics. 2001; 108: 712–718.
32. Donaghue K.C., Chiarelli F., Trotta D. et al. ISPAD Clinical Practice Consensus Guidelines 2006–2007. Microvascular and macrovascular complications. Pediatr. Diabetes. 2007; 8: 163–170.
33. Salomaa V.V., Stranderberg T.E., Vanhanen H. et al. Glucose tolerance and blood pressure: long term follow up in middle age men. BMJ. 1991; 302: 493–496.
34. Visser M., Bouter L.M., Mcquillan G.M. et al. Low grade systemic inflammation in overweight children. Pediatrics. 2001; 107: 13–18.
35. Laakso M. Lipids in type 2 diabetes. Semin. Vasc. Med. 2002; 2: 59–66.
36. Goldberg I.J. Diabetic dyslipidemia: causes and consequences. J. Clin. Endocrinol. Metab. 2001; 86: 965–971.
37. Lewy V.D., Danadian K., Witchel S.F. et al. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J. Pediatr. 2001; 138: 38–44.
38. Strauss R.S., Barlow S.E., Dietz W.H. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J. Pediatr. 2000; 136: 727–733.
39. Shaw R.J., Lamia K.A., Vasquez D. et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005; 9 (310) (5754): 1642–1646.
40. Mannucci E., Ognibene A., Cremasco F. et al. Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects. Diabetes. Care. 2001; 24 (3): 489–494.
41. Jones K.L., Arslanian S., Peterkova V.A. et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2002; 25: 89–94.
Рецензия
Для цитирования:
Васюкова О., Петеркова В. САХАРНЫЙ ДИАБЕТ 2-ГО ТИПА У ДЕТЕЙ И ПОДРОСТКОВ: МЕЖДУНАРОДНЫЕ РЕКОМЕНДАЦИИ. Вопросы современной педиатрии. 2009;8(2):49-53.
For citation:
Vasyukova O., Peterkova V. PANCREATIC DIABETES TYPE 2 IN CHILDREN AND ADOLESCENTS: INTERNATIONAL RECOMMENDATIONS. Current Pediatrics. 2009;8(2):49-53.
Послать статью по эл. почте 
